Santen Pharmaceutical Co., Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SZD.F | OFK.F | REC.MI | YPH.F | D4S.F | NVS | |
|---|---|---|---|---|---|---|
| Market cap | 3.34B | 14.28B | 11.02B | 26.36B | 31.06B | 311.59B |
| P/E (TTM) | 15.8 | 21.7 | 22.3 | 13.0 | 20.3 | 31.5 |
| Forward P/E | 13.5 | — | 14.0 | — | 46.1 | 16.6 |
| Price/book | 2.0 | 10.2 | 5.1 | 2.4 | 3.1 | 8.4 |
| Dividend yield | 2.38% | 1.82% | 2.67% | 3.17% | 3.57% | 2.87% |
| 1-year change | +18.07% | +71.74% | +5.99% | +45.43% | −17.43% | +30.35% |
| Today | +6.12% | +2.99% | −0.19% | +5.76% | +5.64% | +3.59% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All SZD.F news ›Santen Pharmaceutical Co., Ltd. Proposes Year-End Dividend for the Fiscal Year Ended March 31, 2026, Payable on June 24, 2026
Santen Pharmaceutical Co., Ltd. proposed year-end dividend of JPY 19.00 per share for the fiscal year ended March 31, 2026 compared to JPY 19.00 per share paid a year ago. Annual Shareholders Meeting... Santen Pharmaceutical Co., Ltd.…
Santen Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2027
Santen Pharmaceutical Co., Ltd. expects dividend of JPY 21.00 for second quarter-end of fiscal year ending March 31, 2027 as compared to JPY 19.00 per share paid a year ago. For year-end of fiscal... Santen Pharmaceutical Co., Ltd. Santen…
KYORIN Pharmaceutical Co., Ltd. and Santen Pharmaceutical Co., Ltd. Enter Joint Marketing Agreement for Allergic Conjunctivitis Treatment Alesion Cream 0.5%
KYORIN Pharmaceutical Co., Ltd. announced that it has entered into joint marketing agreement in Japan for Alesion eyelid cream 0.5%, , a long-acting treatment for allergic conjunctivitis with Santen... KYORIN Pharmaceutical Co., Ltd…
TriVista Capital CEO: Long on Santen Pharmaceutical
Masaki Gotoh, CEO and CIO at TriVista Capital, discusses his investment strategy in Japan and why he chose to go long on ophthalmology firm Santen Pharmaceutical at the Sohn Hong Kong Investment Leaders Conference. He speaks with Shery Ahn…
Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 13, 2025.
From October 1, 2025 to November 5, 2025, the company has repurchased 3,224,600 shares, representing 0.96% for ¥4,998.66 million. With this, the company has completed the repurchase of 19,800,000... Santen Pharmaceutical Co., Ltd. Tranche…
Santen Pharmaceutical Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2025, Payable on November 28, 2025
Santen Pharmaceutical Co., Ltd. announced dividend for the second quarter ended September 30, 2025, payable on November 28, 2025. For the period the company reported dividend of JPY 19 per share... Santen Pharmaceutical Co., Ltd. Santen…
Santen Pharmaceutical Co., Ltd.: Total Return chart (Dividends reinvested) - Japan Exchange stock market
See the history of Santen Pharmaceutical Co., Ltd., with dividends reinvested. (Total Return chart) 4536 Stock market Total Return chart Santen Pharmaceutical Co., Ltd. Past dividends on Santen Pharmaceutical Co., Ltd. All financial news…
Santen Pharmaceutical Co., Ltd.: Relative Strength Chart - Stock Japan Exchange
Compare Santen Pharmaceutical Co., Ltd. with the company of your choice via a Relative Strength chart. Real-time 4536 price, Japan Exchange stock exchange Relative Strength Chart Santen Pharmaceutical Co., Ltd. All financial news and data…
SpyGlass Pharma, Inc. acquired Advanced Vision Science, Inc. from Santen Pharmaceutical Co., Ltd. for $13 million.
SpyGlass Pharma, Inc. (NasdaqGS:SGP) acquired Advanced Vision Science, Inc. from Santen Pharmaceutical Co., Ltd. (TSE:4536) for $13 million on October 1, 2026. A cash consideration of $13 million will ... (NasdaqGS:SGP) acquired Advanced…
From the 4Search news index, newest first.
In the news
Mentioned with
Most coverage from
- marketscreener.com11
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.